The Physician’s Global Assessment of Fingernail Psoriasis (PGA-F), a new clinician-rating severity scale, was validated in this study.
Cancer survivors, especially survivors of hematologic malignancies, have an increased risk for psoriasis.
The frequency and management of treatment-emergent adverse events of eczema in patients with psoriasis who received ixekizumab is evaluated.
Wynzora is a combination of calcipotriene, a synthetic vitamin D3 analogue, and betamethasone dipropionate, a corticosteroid.
Researchers studied the effect of apremilast on body weight and composition, glucose homeostasis, lipid profiles, and vascular function in psoriatic disease.
The prevalence of psoriasis is 3.0% among the US population aged 20 years or older.
Adults with psoriasis have an increased likelihood of having rheumatoid arthritis (RA) compared with adults without psoriasis.
The real-life effectiveness and safety of ixekizumab injections for the treatment of genital plaque psoriasis was evaluated.
Higher body mass index (BMI) seems to be associated with an increased risk for developing psoriasis.
The prevalence of psoriasis in children and adolescents with type 1 diabetes mellitus is investigated.